Cargando…
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently overexpressed...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156841/ https://www.ncbi.nlm.nih.gov/pubmed/28018216 http://dx.doi.org/10.3389/fphar.2016.00466 |